> top > docs > PMC:7601109 > spans > 5056-5377 > annotations

PMC:7601109 / 5056-5377 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T97716 309-316 Body_part denotes hormone http://purl.org/sig/ont/fma/fma12278

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T82771 0-2 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T7480 5-6 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T18967 56-62 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T49570 223-228 http://purl.obolibrary.org/obo/CLO_0001195 denotes 2 [19

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T15 288-300 Chemical denotes testosterone http://purl.obolibrary.org/obo/CHEBI_17347
T16 302-316 Chemical denotes growth hormone http://purl.obolibrary.org/obo/CHEBI_37845
T17 309-316 Chemical denotes hormone http://purl.obolibrary.org/obo/CHEBI_24621

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T76041 302-308 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T31 5-186 Sentence denotes A large number of pharmacological agents are being tested as anti-sarcopenic agents such as bimagrumab (BYM338), enobasarm (GTx-024), trevogrumab (REGN1033), and sarconeos (BIO101).
T32 187-230 Sentence denotes Most trials are in phase 1 or phase 2 [19].

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
106 302-316 Gene denotes growth hormone Gene:81668
112 97-107 Chemical denotes bimagrumab MESH:C000596367
113 109-115 Chemical denotes BYM338 MESH:C000596367
114 118-127 Chemical denotes enobasarm
115 129-136 Chemical denotes GTx-024 MESH:C547106
116 139-150 Chemical denotes trevogrumab
117 152-160 Chemical denotes REGN1033
118 288-300 Chemical denotes testosterone MESH:D013739